Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD52 antibody (PE)

CD52 Reactivity: Mouse FACS Host: Rat Monoclonal BTG-2G PE
Catalog No. ABIN2853610
  • Target See all CD52 Antibodies
    CD52
    Reactivity
    • 60
    • 11
    • 7
    • 5
    • 4
    • 1
    Mouse
    Host
    • 23
    • 19
    • 19
    • 1
    • 1
    Rat
    Clonality
    • 46
    • 11
    • 3
    Monoclonal
    Conjugate
    • 33
    • 8
    • 7
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This CD52 antibody is conjugated to PE
    Application
    • 48
    • 20
    • 19
    • 16
    • 14
    • 13
    • 12
    • 8
    • 5
    • 5
    • 2
    • 2
    • 1
    Flow Cytometry (FACS)
    Specificity
    This antibody reacts with mouse CD52 antigen.
    Purification
    Protein G agarose
    Immunogen
    IL-2Ralpha-transgenic mouse splenocyte
    Clone
    BTG-2G
    Isotype
    IgG2a
    Top Product
    Discover our top product CD52 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Buffer
    50 tests in 1 mL volume of PBS containing 1 % BSA and 0.09 % NaN3
    Storage
    4 °C
    Storage Comment
    Store at 2-8 °C.
  • Target
    CD52
    Alternative Name
    CD52 / CAMPATH-1 (CD52 Products)
    Synonyms
    CD52 antibody, AI463198 antibody, B7 antibody, B7-Ag antibody, CAMPATH-1 antibody, CLS1 antibody, MB7 antibody, CDW52 antibody, CE5 antibody, CD52 molecule antibody, CD52 antigen antibody, CD52 antibody, Cd52 antibody
    Background
    CAMPATH-1, also known as CD52, is a heavily glycosylated, GPI-anchored protein expressed at high levels on almost all thymocytes, lymphocytes, monocytes, and macrophages. CAMPATH-1 is an exceptionally good target for complement-mediated cell lysis and antibody-mediated cellular cytotoxicity. Humanized CAMPATH-1 antibodies have been used therapeutically to effectively deplete lymphocytes in allogeneic bone marrow transplants, hematologic malignancies, and autoimmune diseases. Clinical trials suggest CAMPATH-1 antibodies are especially promising in the treatment of leukemia, non-Hodgkin lymphomas, and rh eumatoid arthritis. The apparent size of CAMPATH-1 by SDS-PAGE is 25-29 kDa, however, the actual molecule is much smaller, ~ 8-9 kDa as confirmed by total structure analysis and mass spectrometry.Synonyms: CDw52, Cambridge pathology 1 antigen, Epididymal secretory protein E5, HE5
    Gene ID
    23833
    NCBI Accession
    NP_038734
    UniProt
    Q64389
You are here:
Support